Compounds > 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine
Page last updated: 2024-09-03

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and dihydroxyphenylalanine

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine has been researched along with dihydroxyphenylalanine in 1 studies

Compound Research Comparison

Studies
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Trials
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Recent Studies (post-2010)
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Studies
(dihydroxyphenylalanine)		Trials
(dihydroxyphenylalanine)		Recent Studies (post-2010) (dihydroxyphenylalanine)
14108,823322833

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akunne, HC; Cooke, LW; Davis, MD; DeMattos, SB; Georgic, LM; MacKenzie, RG; Rugsley, TA; Shih, YH; van Leeuwen, DH; Whetzel, SZ1

Other Studies

1 other study(ies) available for 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and dihydroxyphenylalanine

ArticleYear
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 4-Butyrolactone; Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Autoreceptors; CHO Cells; Cricetinae; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Guinea Pigs; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin

1995